Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Trial of Danhong Injection in Treating Acute Ischemic Stroke

NCT02152280 is registered in ClinicalTrials.gov with Beijing Bozhiyin T&S Co., Ltd. as lead sponsor.

NCT NCT02152280
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02152280 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Trial of Danhong Injection in Treating Acute Ischemic Stroke
Lead sponsor
Beijing Bozhiyin T&S Co., Ltd.
Phase
Phase 4
Overall status
Unknown status
Start date
March 31, 2014
Completion date
December 31, 2015
Enrollment
320 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

stroke